NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $392,000 | +7.7% | 5,007 | 0.0% | 0.06% | +3.3% |
Q4 2016 | $364,000 | -6.9% | 5,007 | +1.2% | 0.06% | -9.1% |
Q3 2016 | $391,000 | -12.3% | 4,950 | -8.3% | 0.07% | -13.2% |
Q2 2016 | $446,000 | +14.1% | 5,400 | 0.0% | 0.08% | +11.8% |
Q1 2016 | $391,000 | -15.7% | 5,400 | 0.0% | 0.07% | -16.0% |
Q4 2015 | $464,000 | -6.5% | 5,400 | 0.0% | 0.08% | -6.9% |
Q3 2015 | $496,000 | -6.6% | 5,400 | 0.0% | 0.09% | +2.4% |
Q2 2015 | $531,000 | -1.7% | 5,400 | -1.4% | 0.08% | +3.7% |
Q1 2015 | $540,000 | +3.6% | 5,475 | -2.7% | 0.08% | +2.5% |
Q4 2014 | $521,000 | -4.1% | 5,625 | -2.5% | 0.08% | -11.1% |
Q3 2014 | $543,000 | +3.8% | 5,770 | 0.0% | 0.09% | +4.7% |
Q2 2014 | $523,000 | +4.6% | 5,770 | -1.9% | 0.09% | +1.2% |
Q1 2014 | $500,000 | -58.2% | 5,880 | -60.5% | 0.08% | -58.7% |
Q4 2013 | $1,197,000 | -6.3% | 14,896 | -10.5% | 0.21% | -12.7% |
Q3 2013 | $1,277,000 | +8.2% | 16,652 | -0.2% | 0.24% | +5.4% |
Q2 2013 | $1,180,000 | -1.1% | 16,683 | -0.4% | 0.22% | -1.3% |
Q1 2013 | $1,193,000 | – | 16,755 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |